RNS11 May 2020 08:08
Franz Walt, Chief Executive Officer of Quotient, said:
"This collaboration marks a major milestone for our company, and we are proud to collaborate with an industry leader like hVIVO. Quotient has developed what we believe is a gold standard antibody microarray to help combat the COVID-19 pandemic.